Top compounds associated with response to SLC1A2


Feature Type Standardized
Nominal ANOVA
mRNA tivantinib CTRPv2 pan-cancer AAC -0.026 0.6
mRNA tivozanib GDSC1000 pan-cancer AAC 0.034 0.3
mRNA tivozanib CTRPv2 pan-cancer AAC 0.002 1
mRNA tosedostat CTRPv2 pan-cancer AAC -0.011 0.8
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.039 0.3
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.074 0.03
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.014 0.6
mRNA trifluoperazine CTRPv2 pan-cancer AAC 0.066 0.08
mRNA triptolide CTRPv2 pan-cancer AAC 0.034 0.3
mRNA tubastatin A CTRPv2 pan-cancer AAC 0.12 0.01
Download CSV